Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.0091 USD
−235.20 K USD
266.89 K USD
21.71 M
About REPLICEL LIFE SCIENCES INC
Sector
CEO
Andrew Schutte
Headquarters
Vancouver
Website
Founded
1967
FIGI
BBG000PMW6N9
RepliCel Life Sciences, Inc. is a regenerative medicine company, which engages in developing cell therapies for aesthetic and orthopedic conditions. Its products include RCH-01, RCS-01, RCT-01, and DermaPrecise. The company was founded by Kevin McElwee and Rolf Hoffmann on April 24, 1967 and is headquartered in Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of REPCF is 0.0002 USD — it has decreased by −90.48% in the past 24 hours. Watch RepliCel Life Sciences Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange RepliCel Life Sciences Inc. stocks are traded under the ticker REPCF.
REPCF stock has fallen by −90.48% compared to the previous week, the month change is a −80.00% fall, over the last year RepliCel Life Sciences Inc. has showed a −99.70% decrease.
REPCF reached its all-time high on Aug 3, 2004 with the price of 339.0000 USD, and its all-time low was 0.000001 USD and was reached on Nov 1, 2024. View more price dynamics on REPCF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
REPCF stock is 950.00% volatile and has beta coefficient of 3.35. Track RepliCel Life Sciences Inc. stock price on the chart and check out the list of the most volatile stocks — is RepliCel Life Sciences Inc. there?
Today RepliCel Life Sciences Inc. has the market capitalization of 455.41 K, it has increased by 0.66% over the last week.
Yes, you can track RepliCel Life Sciences Inc. financials in yearly and quarterly reports right on TradingView.
RepliCel Life Sciences Inc. is going to release the next earnings report on Nov 26, 2024. Keep track of upcoming events with our Earnings Calendar.
REPCF net income for the last quarter is −137.33 K USD, while the quarter before that showed −185.90 K USD of net income which accounts for 26.13% change. Track more RepliCel Life Sciences Inc. financial stats to get the full picture.
No, REPCF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RepliCel Life Sciences Inc. EBITDA is −598.67 K USD, and current EBITDA margin is −391.47%. See more stats in RepliCel Life Sciences Inc. financial statements.
Like other stocks, REPCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RepliCel Life Sciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RepliCel Life Sciences Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RepliCel Life Sciences Inc. stock shows the strong sell signal. See more of RepliCel Life Sciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.